Cheng, H., Zhang, Z., Borczuk, A., Powell, C. A., Balajee, A. S., Lieberman, H. B., & Halmos, B. (2013). PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells. Oxford University Press.
Chicago Style CitationCheng, Haiying, Zhenfeng Zhang, Alain Borczuk, Charles A. Powell, Adayabalam S. Balajee, Howard B. Lieberman, i Balazs Halmos. PARP Inhibition Selectively Increases Sensitivity to Cisplatin in ERCC1-low Non-small Cell Lung Cancer Cells. Oxford University Press, 2013.
Cita MLACheng, Haiying, et al. PARP Inhibition Selectively Increases Sensitivity to Cisplatin in ERCC1-low Non-small Cell Lung Cancer Cells. Oxford University Press, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.